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ABSTRACT 
 
This study aimed to evaluate if the splenectomy alters the biodistribution of 99mTc-DMSA and renal function in 
Wistar rats. The animals were separated in the groups: splenectomy (n = 6) and control (n = 6). After splenectomy 
(15 days), the administration of 0.1ml of 99mTc-DMSA IV (0.48 MBq) was carried out. Thirty minutes later, kidney, 
heart, lung, thyroid, stomach, bladder and femur and samples of blood were isolated. The organs were weighed, 
counted and the percentage of radioactivity /g (%ATI/g) determined. Serum urea and creatinine, hematocrit, 
leukocytes and platelets were measured. Statistics by t test (p<0.05) was done. There was a significant reduction in 
%ATI/g in kidney and blood (p<0.05) of splenectomized animals, a significant increase (p<0.05) of urea (88.8 ± 
18.6 mg/dL) and creatinine (0.56 ± 0.08 mg/dL), compared to the controls (51.5±1.6, 0.37±0.02mg/dL, 
respectively), as well as increase in platelets and leucocytes, and hematocrit reduction. The analysis of the results 
indicates that in rats, splenectomy seems to alter the renal function and the uptake of 99mTc-DMSA.  
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INTRODUCTION 
 
The spleen has a complex physiologic role, as 
evidenced by its multiple immunologic, filtration, 
reservoir, and hematopoietic functions. It is more 
efficient in removing non-opsonized bacteria, 
mostly encapsulated organisms, than is the liver. It 
is the main site of the opsonins, tuftsin and 
properdin, as well as of immunoglobulin-M 
antibody synthesis (Brendolan et al., 2007). 
Splenectomy has been indicated for trauma, tumor 
and hematological disorders (Petroianu, 2005).  In 
some splenectomized patients severe infection and 
disseminated intravascular coagulation (DIC) with 
post-mortem congestion in every organ as well as 
bleeding may occur. Frequent causes of death are 
progressive renal failure, pneumococcal sepsis, 
DIC, hemorrhage, pulmonary and renal congestion 
(Tajiri et al., 2007).  
Technetium-99m-dimercaptosuccinic acid 
(99mTc-DMSA) scintigraphy is the standard 
method used to evaluate permanent renal damage 
in children with urinary tract infection (Stokland et 
al., 2007; Piepsz et al., 1999). The use of 99mTc-
DMSA for renal cortical scintigraphy, introduced 
in the 1970s, has been shown to be sensitive and 
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specific for diagnosing pyelonephritis in children 
(Majd and Rushton, 1992). Quantitative single-
photon emission computed tomography (SPECT) 
measurement of 99mTc-DMSA uptake by the 
kidneys is a reproducible method that can reliably 
be used to monitor serial changes in individual 
renal function. The method provides information 
concerning the percentage injected dose per cubic 
centimeter of renal tissue and functional kidney 
volumes, and can obtain individual kidney uptake, 
which provides a practical index for evaluating 
individual renal function (Groshar et al., 1997). 
The renal uptake of 99mTc-DMSA is dependent 
on renal blood flow and proximal tubular cell 
membrane transport function (Taylor, 1982, Saha, 
2004).  
When a radiopharmaceutical is administered to a 
patient, the process of biodistribution begins; this 
consists of absorption, distribution, metabolism 
and excretion. The biodistribution of 
radiopharmaceuticals can be changed by surgical 
procedures performed in animal models (Araújo-
Filho et al., 2007; Chacon et al., 2007). The 
biodistribution of radiopharmaceuticals is based on 
the same pharmacokinetic principles described for 
therapeutic agents. So, when a patient is using a 
given drug, or was previously submitted to a 
surgical procedure, the biodistribution of a 
radiopharmaceutical injected intravenously to 
perform scintigraphy might change.  
In spite of the evidence of renal complications in 
the postoperative of splenectomy, this problem has 
been scarcely studied. The present study aimed at 
investigating whether splenectomy could change 
the biodistribution of 99mTc-DMSA in some 
organs of rats and could affect the red blood cells, 
white blood cell and platelet count and the urea 
and creatinine concentrations.  
 
 
MATERIAL AND METHODS 
 
Male Wistar rats, weighing 295±31g, were 
supplied by the Center of Experimental Surgery of 
the Federal University of Rio Grande do Norte, 
Brazil. The animals were housed under standard 
conditions, and fed rodent chow and water ad 
libitum. The protocol for this study was approved 
by the Institutional Animal Care Committee, and 
all surgical procedures and care administered to 
the animals were in accordance with Brazilian 
College of Animal Experimentation guidelines.  
After 7 days of acclimatization in the laboratory, 
the rats were randomly allocated to two groups of 
6 rats each. The groups were denominated 
splenectomy (SP) and control (C).  
After overnight fast, the rats were anesthetized 
with intraperitoneal thiobarbital (20 mg/kg weight) 
and ketamine (50 mg/kg weight) intra-muscular 
(IM). A midline laparotomy was performed after 
the skin was shaved and sterilized with 70% 
ethanol. The spleens of SP group rats were 
removed. The laparotomy wound was closed with 
4-0 nylon in layers and individual rats were placed 
in separate cages. They were allowed water ad 
libitum and rat chow after 24 h postoperatively. 
The C rats (n=6) were neither anesthetized nor 
operated on. Hydration was performed with 
normal 0.9% NaCl solution (saline) injected 
subcutaneously in the back of the rats for the first 
two postoperative days. Postoperative pain was 
treated with tenoxicam (Roche Pharm., Brazil); 10 
mg/kg was given IM to the rats once a day for the 
first three days. Body weight was monitored 
weekly throughout the entire 15-day experimental 
period. Activity, mucosa and skin color were 
observed daily. 
On the 15th day all the animals were anesthetized 
again, and injected with 0.lmL of 99mTc-DMSA 
(0.66 MBq) in the orbital plexus. After 30 min, 
blood was collected by cardiac puncture for 
dosages and the animals were killed by a lethal 
dose of anesthetic. Kidney, heart, lung, thyroid, 
stomach, bladder and femur were isolated and 
samples of blood were separated. The organs were 
washed in saline, weighed on a balance (Bel-Mark 
160-II Itália) and the radioactivity counted using 
a 1470 WizardTM Gamma Counter - Perkin-Elmer, 
Finland, with automatic correction of radiation 
decay. The percentage of radioactivity/g (%ATI/g) 
of each organ was calculated by dividing the 
activity per gram of the sample tissues by the total 
activity administered to each animal.  
Serum urea and creatinine were measured with a 
Konelab 60i Spectrophotometer (assay kit from 
Weiner, São Paulo, Brazil). Hematological 
analysis of hematocrit (HCT), white blood cells 
(WBC) and platelets was performed using an 
Abbot Cell Dyn 3500 Automatic Analyzer, São 
Paulo, Brazil. The data were expressed as 
mean±standard deviation (SD). Group comparison 
was made using ANOVA and the post-hoc Student 
test, with a significance level set at p<0.05. 
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RESULTS 
 
Table 1 shows significant decrease of radioactivity 
(Tc-99m-DMSA) in the kidney and on blood 
uptake in animals submitted to splenectomy than 
those found in control rats (p<0.05). The 
radioactive uptake predominated in the kidney and 
in bone (femur). Specifically, the lung had higher 
uptake in splenectomized rats than in controls 
(p=0.008). In the other organs (heart, thyroid, 
stomach, bladder and femur) we did not detect 
significant differences in 99mTc-DMSA uptake 
between splenectomized and control rats (p>0.05). 
Postsplenectomy symptoms such as hematuria, 
pale mucosa and lethargy were observed in 6 
animals, but not in control rats. We observed no 
significant body weight loss in splenectomized 
rats, compared to controls.  
 
Table 1 - Results of 99mTc-DMSA biodistribution in rats (splenectomy and control). 
%ATI/g 
Organs 
Splenectomy Control 
P 
Kidney 2.10 ± 0.30 3.27 ± 0.81 0.041 
Heart 0.13 ± 0.04 0.12 ± 0.02 0.066 
Lung 0.23 ± 0.05 0.12 ± 0.06 0.008 
Thyroid 0.07 ± 0.02 0.06 ± 0.02 0.357 
Stomach 0.08 ± 0.02 0.06 ± 0.02 0.225 
Bladder 0.34 ± 0.43 0.42 ± 0.35 0.736 
Fêmur 2.04 ± 0.01 1.93 ± 0.01 0.924 
Blood 0.30 ± 0.09 0.53 ± 0.16 0.012 
Mean±Standard deviation; %ATI/g, percent of  radioactivity per gram. 
 
 
To examine the effects of prior splenectomy on 
kidney injury, we assessed the levels of urea and 
creatinine (Table 2). In splenectomized rats, urea 
and creatinine values (88.3 ± 18.5 mg/dL and 0.56 
± 0.08 mg/dL respectively) were significantly 
(p<0.05) higher than in controls (51.7 ± 1.3 mg/dL 
and 0.37 ± 0.02 mg/dL respectively).  Changes in 
platelet and WBC counts are summarized in Table 
2. At postoperative day 15, the number of platelets 
and WBC were significantly higher in 
splenectomized rats than in controls (p<0.05). 
Hematocrit was significantly lower in 
splenectomized rats (22.8±4.7%) than in controls 
(46.8±9.02%; p=0.0002). 
 
 
Table 2 - Values of urea, creatinine, platelets, hematocrit (HCT) and white blood cell (WBC) in rats after 
splenectomy. 
Dosages Splenectomy Control p 
Urea (mg/dL) 88.3 ± 18.5 51.7 ± 1.3 0.01 
Creatinine (mg/dL) 0.56 ± 0.08 0.37 ± 0.02 0.0014 
Platelets(k/µL) 1252 ± 248 530 ± 251 0.002 
HCT (%) 22.8 ± 4.7 46.8 ± 9.02 0.0002 
WBC (k/µL) 15.2 ± 2.9 3.3 ± 0.8 <0.001 
Mean±standard deviation; WBC, white blood cells; p-value from t test for independent samples; HCT, hematocrit. 
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DISCUSSION 
 
During the last years, non operative management 
has become the primary method of preserving the 
spleen. Splenectomy is required for around 50% of 
splenic trauma injuries (Velmahos et al., 2000). 
The white blood cell count (WBC) is an integral 
part of sepsis diagnosis. Early WBC trends alert 
the physician about the possibility of sepsis and 
allow prompt therapeutic response. However,   
postsplenectomy diagnosis of sepsis based on 
elevated WBC is not suitable due to the fact that 
leukocytosis is a physiologic response to 
splenectomy, similar to the phenomenon of 
elevated postsplenectomy platelet count (Bessler et 
al., 2004). Some reports suggest that 
postsplenectomy WBC in patients with sepsis is 
greater and more persistent than the WBC in 
patients without sepsis (Rutherford et al., 1994).  
In our study, we tried to verify if splenectomy was 
able to alter the biodistribution of 99mTc-DMSA 
to some organs, especially to the kidneys, the 
preferential uptake target of this 
radiopharmaceutical. As all animals had 
hematuria, leukocytosis and a significant platelet 
increase, we suspect that the splenectomized 
animals were affected by sepsis associated with 
disseminated intravascular coagulation. Increased 
white blood cell count and platelets are frequently 
the only hematological abnormalities observed in 
splenectomized patients (Petroianu et al., 2006). 
The phenomenon of temporary leukocytosis 
following splenectomy has been well known for 
many decades as a physiologic response to 
removal of the spleen. Leukocytosis is also a 
prominent finding of postoperative sepsis, a 
common and much feared complication of 
splenectomy. Therefore, confusion exists as to 
whether postsplenectomy leukocytosis should be 
considered a normal finding or a warning sign 
mandating treatment (Horowitz et al., 1992). 
Associated with hematuria, the animals in this   
study had significant kidney function impairment, 
due to the increase in urea and serum creatinine. 
These findings may explain the reduction in 
99mTc-DMSA uptake by renal parenchyma, 
reinforcing the characterization of 
postsplenectomy renal failure in rats. 
Most authors encourage using DMSA scintigraphy 
for the early diagnosis of many diseases, because 
of its cost-effectiveness and safety. A focal 
reduction or absence of uptake in one or more 
areas of the kidney is considered abnormal, 
indicating renal damage. In positive cases, DMSA 
scintigraphy is found to be highly sensitive in 
detecting multiple lesions (Piepsz et al., 1999; 
Stogianni et al., 2007). Besides leukocytosis and 
renal impairment evidenced by changes in urea 
and creatinine, we observed that the 
splenectomized animals had intense anemia 
associated with low hematocrit in all operated rats. 
In fact, they all showed clear signs of pale mucosa 
and hematuria at the 15th postoperative day. 
Certainly these hematologic findings could be 
contributing to the renal failure and to the low 
uptake of the radiopharmaceutical in the blood of 
splenectomized animals.  
In conclusion, the results suggest that splenectomy 
in rats results in important hematological changes 
as well as impairment in renal function and Tc-
99m-DMSA uptake. 
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RESUMO 
 
Estudo com objetivo de avaliar se a esplenectomia 
altera a biodistribuição do 99mTc-DMSA e alguns 
parâmetros bioquímicos e hematológicos em ratos 
Wistar. Os animais forma divididos em 2 grupos: 
esplenectomizados (n=6) e  controle(n=6). Após 
15 dias, administração de 0,1 ml de 99mTc-DMSA 
via plexo orbital (0,48 MBq) foi realizada. Rim, 
coração, pulmão, tireóide, estômago, bexiga e 
fêmur e amostras de sangue foram separadas. Após 
pesagem e contagem da radioatividade foi 
determinado o percentual de radioatividade/g (% 
ATI/g). Dosadas uréia e creatinina sérica, 
hematócrito, plaquetas e leucócitos. Estatística 
pelo teste t, significância 0,05 foi realizada. Foi 
observada redução significante no %ATI/g no rim 
e sangue (p<0,05) dos animais esplenectomizados, 
aumento significante (p<0.05) da uréia (88,8±18,6 
mg/dL) e creatinina (0,56±0,08), comparado aos 
controles (51,5±1,6;  0,37±0,02mg/dL, 
respectivamente) assim como aumento de 
leucócitos e plaquetas e redução de hematócrito. 
Conclui-se que em ratos, a esplenectomia alterou a 
captação de 99mTc-DMSA pelo rim, e a função 
renal.  
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